Skip to content

Clinical trials

Lymphoma, T-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Clear all

276 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20044
20052
20066
20076
20089
200913
20108
201111
20127
201315
20146
20159
201614
201720
201813
201918
202018
202118
202215
202316
202414
202514
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed108
Recruiting53
Unknown status41
Terminated38
Active, not recruiting17
Withdrawn9
Not yet recruiting5
Suspended3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)21
M.D. Anderson Cancer Center17
City of Hope Medical Center8
Memorial Sloan Kettering Cancer Center8
Mayo Clinic7
Fred Hutchinson Cancer Center6
Masonic Cancer Center, University of Minnesota5
Yale University5
Institute of Hematology & Blood Diseases Hospital, China4
Acrotech Biopharma Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell276
Lymphoma68
Lymphoma, Non-Hodgkin48
Lymphoma, Large-Cell, Anaplastic47
Lymphoma, T-Cell, Cutaneous44
Immunoblastic Lymphadenopathy41
Lymphoma, Large B-Cell, Diffuse41
Hodgkin Disease40
Lymphoma, B-Cell40
Lymphoma, T-Cell, Peripheral39

Trials

Showing 26 to 50 of 276. Each trial links to its page on Pharma Observatory.

176 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.